Use of Azithromycin in COVID-19: A Cautionary Tale

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetter

Abstract

The novel coronavirus disease 2019 (COVID-19) pandemic has seen many drugs being repositioned or repurposed for the treatment of COVID-19. Among the repurposed drugs, azithromycin has caught the limelight, where it is frequently administered to patients with COVID-19 alongside chloroquine or hydroxychloroquine.
Original languageEnglish
Pages (from-to)989-990
Number of pages2
JournalClinical Drug Investigation
Volume40
Issue number10
Early online date20 Aug 2020
DOIs
Publication statusPublished - 1 Oct 2020

Fingerprint Dive into the research topics of 'Use of Azithromycin in COVID-19: A Cautionary Tale'. Together they form a unique fingerprint.

  • Cite this